Inventor
Chunsheng GAO
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
B82YSpecific uses or applications of nanostructures15%
C08BPolysaccharides15%
C08LCompositions of macromolecular compounds15%
B02CCrushing, pulverising, or disintegrating in general8%
G06FElectric digital data processing8%
PatentTitleYear
11,628,445Material crushing cavity structure and method for designing a multi-stage nested material crushing cavity structure202311,369,587Injectable pharmaceutical composition of tecovirimat and preparation method thereof202211,318,115Oral pharmaceutical composition of Tecovirimat and preparation method thereof202211,260,031Protein particle with a poorly water-soluble drug encapsulated therein and preparation method thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA (2)· patent assignee history
2022Patents assigned to ACAD OF MILITARY MEDICAL SCIENCES (1)· patent assignee history
2022Patents assigned to INST OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES PLA CHINA (1)· patent assignee history
2022–2023Based in CN· patent location history
2023Patents assigned to UNIV JIANGXI SCI & TECHNOLOGY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA | 2 | 2022 |
| ACAD OF MILITARY MEDICAL SCIENCES | 1 | 2022 |
| INST OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES PLA CHINA | 1 | 2022 |
| UNIV JIANGXI SCI & TECHNOLOGY | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2022–2023 |